WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad

The U.S. FDA issues seven observations to Dr. Reddy's Hyderabad biologics facility following a pre-licence inspection.

Raccontata dathehindu.comfiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
thehindu.comStai leggendo5 g fa

U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad

The U.S. FDA issues seven observations to Dr. Reddy's Hyderabad biologics facility following a pre-licence inspection.

originale
fiercepharma.com4 g fa

FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483

A June inspection now has the FDA hitting Dr. | The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-June inspection.

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 26 giugno 2026·thehindu.com

    U.S. FDA issues seven observations to Dr. Reddy’s biologics manufacturing facility in Hyderabad

    The U.S. FDA issues seven observations to Dr. Reddy's Hyderabad biologics facility following a pre-licence inspection.

  2. venerdì 26 giugno 2026·fiercepharma.com

    FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483

    A June inspection now has the FDA hitting Dr. | The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-June inspection.